ACON Injectable Investors I, L.P. — Form D
ACON Injectable Investors I, L.P. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-01. The offering totals $74.0M, of which $59.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-06-01
- Form: D
- Accession: 0001865102-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b, 3C, 3C.7
- Total offering: $74.0M
- Amount sold: $59.0M
- Remaining: $15.0M
- Investors: 3
- Date of first sale: 2021-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401230
Issuer
- Name: ACON Injectable Investors I, L.P.
- CIK: 0001865102
- Entity type: Limited Partnership
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2021
- Address: C/O ALAOF V GENPAR, L.L.C., WASHINGTON, DC, 20036
- Phone: (202) 454-1100
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Teresa Y Bernstein | Executive Officer | Washington D.C., DC |
| Jose Knoell | Executive Officer | Washington, DC |
| Masumi Y Waida | Executive Officer | Washington D.C., DC |
| N/A ALAOF V GenPar, L.L.C. | Promoter | Washington, DC |
More